✉ Email this page to a colleague
« Back to Dashboard
Amrix is a drug marketed by Teva Pharms Intl and is included in one NDA. There are seven patents protecting this drug and one Paragraph IV challenge.
This drug has one patent family member in one country.
The generic ingredient in AMRIX is cyclobenzaprine hydrochloride. There are sixteen drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the cyclobenzaprine hydrochloride profile page.
A generic version of AMRIX was approved as cyclobenzaprine hydrochloride by ACTAVIS LABS FL INC on May 3rd, 1989.
Summary for AMRIX
|Finished Product Suppliers / Packagers:
|Raw Ingredient (Bulk) Api Vendors:
|Formulation / Manufacturing:
|Drug price information for AMRIX
|Patent Litigation and PTAB cases:
|See patent lawsuits and PTAB cases for AMRIX
|What excipients (inactive ingredients) are in AMRIX?
|AMRIX excipients list
|AMRIX at DailyMed
AMRIX is protected by seven US patents.
Patents protecting AMRIX
See the table below for patents covering AMRIX around the world.